Research advances of biomarkers related to congenital hydronephrosis

References:

[1] 孙宁,郑珊.小儿外科学[M].北京:人民卫生出版社,2015. Sun N,Zheng S.Pediatric Surgery[M].Beijing:People’s Medical Publishing House,2015.
[2] 中华医学会小儿外科分会泌尿外科学组.先天性肾盂输尿管交界处梗阻诊疗专家共识[J].中华小儿外科杂志,2018,39(11):804-810.DOI:10.3760/cma.j.issn.0253-3006.2018.11.002. Group of Urology,Branch of Pediatric Surgery,Chinese Medical Association:Expert Consensus on Diagnosing and Treating Congenital Ureteropeivic Junction Obstruction[J].Chin J Pediatr Surg,2018,39(11):804-810.DOI:10.3760/cma.j.issn.0253-3006.2018.11.002.
[3] 胡梅艳,孙晓红.细胞外基质、基质金属蛋白酶与恶性肿瘤关系的研究进展[J].肿瘤药学,2016,6(1):26-30.DOI:10.3969/j.issn.2095-1264.2016.01.06. Hu MY,Sun XH.Research advances of relationship between ECM,MMPs and malignant tumors[J].Anti-Tumor Pharm,2016,6(1):26-30.DOI:10.3969/j.issn.2095-1264.2016.01.06.
[4] Tan TK,Zheng GP,Hsu TT,et al.Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells[J].Am J Pathol,2010,176(3):1256-1270.DOI:10.2353/ajpath.2010.090188.
[5] Zhou D,Tian Y,Sun L,et al.Matrix metalloproteinase-7 is a urinary biomarker and pathogenic mediator of kidney fibrosis[J].J Am Soc Nephrol,2017,28(2):598-611.DOI:10.1681/ASN.2016030354.
[6] He WC,Dai CS,Li YJ,et al.Wnt/beta-catenin signaling promotes renal interstitial fibrosis[J].J Am Soc Nephrol,2009,20(4):765-776.DOI:10.1681/ASN.2008060566.
[7] 秦双利,谢崇,周玲,等.儿童肾盂输尿管连接部梗阻患者尿液中MMP-7和MMP-9的临床意义[J].临床小儿外科杂志,2021,20(7):664-667.DOI:10.12260/lcxewkzz.2021.07.013. Qin SL,Xie C,Zhou L,et al.Evaluation of matrix metalloproteinase-7 and matrix metalloproteinase-9 as biomarkers for ureteropelvic junction obstruction in children[J].J Clin Ped Sur,2021,20(7):664-667.DOI:10.12260/lcxewkzz.2021.07.013.
[8] Bienia[KG-0.92mm]s[DD(-1*9][HT6.]＇[HT6] B,Sikora P.Selected metal matrix metalloproteinases and tissue inhibitors of metalloproteinases as potential biomarkers for tubulointerstitial fibrosis in children with unilateral hydronephrosis[J].Dis Markers,2020,2020:9520309.DOI:10.1155/2020/9520309.
[9] Mello MF,Thalita Dos Reis S,Kondo EY,et al.Urinary extracellular matrix proteins as predictors of the severity of ureteropelvic junction obstruction in children[J].J Pediatr Urol,2021,17(4):438.e1-438.e7.DOI:10.1016/j.jpurol.2021.03.017.
[10] Reis ST,Leite KRM,Viana NI,et al.MMP9 overexpression is associated with good surgical outcome in children with UPJO:preliminary results[J].BMC Urol,2016,16(1):44.DOI:10.1186/s12894-016-0162-6.
[11] Bleyer AJ,Kmoch S.Tamm-horsfall glycoprotein and uromodulin:it is all about the tubules[J].Clin J Am Soc Nephrol,2016,11(1):6-8.DOI:10.2215/CJN.12201115.
[12] Kraus D,Wanner C.Uromodulin in the bloodstream:old wine in a new wineskin[J].J Am Soc Nephrol,2017,28(7):1955-1957.DOI:10.1681/ASN.2017040447.
[13] Delgado GE,Kleber ME,Scharnagl H,et al.Serum uromodulin and mortality risk in patients undergoing coronary angiography[J].J Am Soc Nephrol,2017,28(7):2201-2210.DOI:10.1681/ASN.2016111162.
[14] 赵智凝,武易,刘芳,等.慢性肾病患者血清Klotho,HE4,UMOD表达水平与疾病预后的相关性研究[J].现代检验医学杂志,2021,36(2):28-31,56.DOI:10.3969/j.issn.1671-7414.2021.02.007. Zhao ZN,Wu Y,Liu F,et al.Correlation between the expression levels of Klotho,HE4 and uromodulin and the development of chronic kidney disease[J].J Mod Lab Med,2021,36(2):28-31,56.DOI:10.3969/j.issn.1671-7414.2021.02.007.
[15] 尤瑞莲,徐鲁斌,陈丽萌.尿调节素及UMOD基因与慢性肾病的相关性研究进展[J].基础医学与临床,2020,40(4):557-561.DOI:10.3969/j.issn.1001-6325.2020.04.025. You RL,Xu LB,Chen LM.Research advances in the correlation of uromodulin and UMOD gene with chronic kidney diseases[J].Basic Clin Med,2020,40(4):557-561.DOI:10.3969/j.issn.1001-6325.2020.04.025.
[16] Bachmann S.A novel role for Tamm-Horsfall protein (uromodulin) in the renal tubule[J].Kidney Int,2018,94(4):652-655.DOI:10.1016/j.kint.2018.06.023.
[17] Liu Y,Mo L,Goldfarb DS,et al.Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein[J].Am J Physiol Renal Physiol,2010,299(3):F469-F478.DOI:10.1152/ajprenal.00243.2010.
[18] Steubl D,Block M,Herbst V,et al.Plasma uromodulin correlates with kidney function and identifies early stages in chronic kidney disease patients[J].Medicine (Baltimore),2016,95(10):e3011.DOI:10.1097/MD.0000000000003011.
[19] Schaeffer C,Devuyst O,Rampoldi L.Uromodulin:roles in health and disease[J].Annu Rev Physiol,2021,83:477-501.DOI:10.1146/annurev-physiol-031620-092817.
[20] 闫动,张蕾,刘超.糖类抗原19-9作为先天性肾积水生化标志物的研究进展[J].中华小儿外科杂志,2022,43(5):476-480.DOI:10.3760/cma.j.cn421158-20210309-00109. Yan D,Zhang L,Liu C.Research advances of carbohydrate antigen 19-9 as a biochemical marker of congenital hydronephrosis[J].Chin J Pediatr Surg,2022,43(5):476-480.DOI:10.3760/cma.j.cn421158-20210309-00109.
[21] Suzuki K,Muraishi O,Tokue A.The correlation of serum carbohydrate antigen 19-9 with benign hydronephrosis[J].J Urol,2002,167(1):16-20.
[22] Amini E,Pishgar F,Hojjat A,et al.The role of serum and urinary carbohydrate antigen 19-9 in predicting renal injury associated with ureteral stone[J].Ren Fail,2016,38(10):1626-1632.DOI:10.1080/0886022X.2016.1202732.
[23] Miranda EP,Duarte RJ,de Bessa JJr,et al.The role of urinary KIM-1,NGAL,CA19-9 and β2-microglobulin in the assessment of ureteropelvic junction obstruction in adults[J].Biomarkers,2017,22(7):682-688.DOI:10.1080/1354750X.2017.1284264.
[24] Kajbafzadeh AM,Elmi A,Talab SS,et al.Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children[J].J Urol,2010,183(6):2353-2360.DOI:10.1016/j.juro.2010.02.031.
[25] Fendereski K,Nabighadim A,Seyedtabib M,et al.Comparing predictive values of carbohydrate antigen 19-9,neutrophil gelatinase-associated lipocalin,and kidney injury molecule-1 in 161 patients with ureteropelvic junction obstruction[J].Pediatr Nephrol,2021,36(3):631-638.DOI:10.1007/s00467-020-04750-w.
[26] ?zkuvanc? V,D?nmez M[KG-1.1mm]I[DD(-*3]·,Ziylan O,et al.Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis?[J].J Pediatr Urol,2020,16(6):844.e1-844.e7.DOI:10.1016/j.jpurol.2020.09.005.
[27] Kajbafzadeh AM,Sabetkish S,Sabetkish N.Prognostic significance of maternal urinary carbohydrate antigen 19-9 for antenatal diagnosis of posterior urethral valve associated with fetal hydronephrosis[J].Int Urol Nephrol,2019,51(6):909-915.DOI:10.1007/s11255-019-02138-w.
[28] Akba? M,Koyuncu FM,Artun? Vlkümen B,et al.Can maternal urinary and serum carbohydrate antigen 19-9 concentrations be utilized in the diagnosis of fetal hydronephrosis?[J].J Turk Ger Gynecol Assoc,2020,21(1):41-45.DOI:10.4274/jtgga.galenos.2019.2019.0101.
[29] Omar B,Banke E,Guirguis E,et al.Regulation of the pro-inflammatory cytokine osteopontin by GIP in adipocytes-a role for the transcription factor NFAT and phosphodiesterase 3B[J].Biochem Biophys Res Commun,2012,425(4):812-817.DOI:10.1016/j.bbrc.2012.07.157.
[30] Icer MA,Gezmen-Karadag M.The multiple functions and mechanisms of osteopontin[J].Clin Biochem,2018,59:17-24.DOI:10.1016/j.clinbiochem.2018.07.003.
[31] Vianello E,Kalousová M,Dozio E,et al.Osteopontin:the molecular bridge between fat and cardiac-renal disorders[J].Int J Mol Sci,2020,21(15):5568.DOI:10.3390/ijms21155568.
[32] Kaleta B.The role of osteopontin in kidney diseases[J].Inflamm Res,2019,68(2):93-102.DOI:10.1007/s00011-018-1200-5.
[33] Frangogiannis NG.Matricellular proteins in cardiac adaptation and disease[J].Physiol Rev,2012,92(2):635-688.DOI:10.1152/physrev.00008.2011.
[34] Hudkins KL,Giachelli CM,Cui Y,et al.Osteopontin expression in fetal and mature human kidney[J].J Am Soc Nephrol,1999,10(3):444-457.DOI:10.1681/ASN.V103444.
[35] Xie Y,Sakatsume M,Nishi S,et al.Expression,roles,receptors,and regulation of osteopontin in the kidney[J].Kidney Int,2001,60(5):1645-1657.DOI:10.1046/j.1523-1755.2001.00032.x.
[36] Hara I,Miyake H,Yamanaka K,et al.Expression of CD44 adhesion molecules in nonpapillary renal cell carcinoma and normal kidneys[J].Urology,1999,54(3):562-566.DOI:10.1016/s0090-4295(99)00177-6.
[37] Yamate T,Kohri K,Umekawa T,et al.Interaction between osteopontin on madin darby canine kidney cell membrane and calcium oxalate crystal[J].Urol Int,1999,62(2):81-86.DOI:10.1159/000030363.
[38] Giachelli CM,Pichler R,Lombardi D,et al.Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis[J].Kidney Int,1994,45(2):515-524.DOI:10.1038/ki.1994.67.
[39] Padanilam BJ,Martin DR,Hammerman MR.Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats[J].Endocrinology,1996,137(5):2133-2140.DOI:10.1210/endo.137.5.8612558.
[40] Eddy AA,Giachelli CM.Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria[J].Kidney Int,1995,47(6):1546-1557.DOI:10.1038/ki.1995.218.
[41] Wüthrich RP,Fan X,Ritthaler T,et al.Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis[J].Autoimmunity,1998,28(3):139-150.DOI:10.3109/08916939808996282.
[42] Magil AB,Pichler RH,Johnson RJ.Osteopontin in chronic puromycin aminonucleoside nephrosis[J].J Am Soc Nephrol,1997,8(9):1383-1390.DOI:10.1681/ASN.V891383.
[43] Nambi P,Gellai M,Wu HL,et al.Upregulation of osteopontin in ischemia-induced renal failure in rats:a role for ET-1?[J].Biochem Biophys Res Commun,1997,241(1):212-214.DOI:10.1006/bbrc.1997.7791.
[44] 张宇,王宏权,李俞润,等.鹿角形肾结石并发肾盂感染的危险因素及肾组织骨桥蛋白、NF-κB表达水平[J].中华医院感染学杂志,2022,32(17):2657-2661.DOI:10.11816/cn.ni.2022-211905. Zhang Y,Wang HQ,Li YR,et al.Risk factors for renal pelvic infection and expression levels of osteopontin and NF-κB in renal tissues of patients with renal staghorn calculi[J].Chin J Nosocomiol,2022,32(17):2657-2661.DOI:10.11816/cn.ni.2022-211905.
[45] Kaneto H,Morrissey J,McCracken R,et al.Osteopontin expression in the kidney during unilateral ureteral obstruction[J].Miner Electrolyte Metab,1998,24(4):227-237.DOI:10.1159/000057375.
[46] Madsen MG,N?rregaard R,Palmfeldt J,et al.Urinary NGAL,cystatin C,β2-microglobulin,and osteopontin significance in hydronephrotic children[J].Pediatr Nephrol,2012,27(11):2099-2106.DOI:10.1007/s00467-012-2217-6.
[47] Madsen MG.Urinary biomarkers in hydronephrosis[J].Dan Med J,2013,60(2):B4582.
[48] Devarakonda CKV,Shearier ER,Hu CR,et al.A novel urinary biomarker protein panel to identify children with ureteropelvic junction obstruction-A pilot study[J].J Pediatr Urol,2020,16(4):466.e1-466.e9.DOI:10.1016/j.jpurol.2020.05.163.
[49] Chen HH,Lin HW,Xu MS,et al.Quantitative urinary proteome reveals potential biomarkers for ureteropelvic junction obstruction[J].Proteomics Clin Appl,2019,13(4):e1800101.DOI:10.1002/prca.201800101.
[50] 孙婕,孙宁.儿童肾盂输尿管连接部梗阻生物标志物的研究进展[J].中华小儿外科杂志,2021,42(10):949-955.DOI:10.3760/cma.j.cn421158-20200430-00303. Sun J,Sun N.Recent advances of ureteropelvic junction obstruction biomarkers in children[J].Chin J Pediatr Surg,2021,42(10):949-955.DOI:10.3760/cma.j.cn421158-20200430-00303.
[51] Bienia? B,Sikora P.Potential novel biomarkers of obstructive nephropathy in children with hydronephrosis[J].Dis Markers,2018,2018:1015726.DOI:10.1155/2018/1015726.
[52] Karakus S,Oktar T,Kucukgergin C,et al.Urinary IP-10,MCP-1,NGAL,cystatin-C,and KIM-1 levels in prenatally diagnosed unilateral hydronephrosis:the search for an ideal biomarker[J].Urology,2016,87:185-192.DOI:10.1016/j.urology.2015.09.007.
[53] Taha MA,Shokeir AA,Osman HG,et al.Pelvi-ureteric junction obstruction in children:the role of urinary transforming growth factor-beta and epidermal growth factor[J].BJU Int,2007,99(4):899-903.DOI:10.1111/j.1464-410X.2006.06641.x.
[54] Almodhen F,Loutochin O,Capolicchio JP,et al.The role of bladder urine transforming growth factor-beta1 concentrations in diagnosis and management of unilateral prenatal hydronephrosis[J].J Urol,2009,182(1):292-298.DOI:10.1016/j.juro.2009.02.132.
[55] Li ZZ,Zhao ZZ,Liu XH,et al.Prediction of the outcome of antenatal hydronephrosis:significance of urinary EGF[J].Pediatr Nephrol,2012,27(12):2251-2259.DOI:10.1007/s00467-012-2243-4.
[56] Yu L,Zhou L,Li Q,et al.Elevated urinary lipocalin-2,interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction[J].J Pediatr Urol,2019,15(1):44.e1-44.e7.DOI:10.1016/j.jpurol.2018.10.007.
[57] Mohammadjafari H,Rafiei A,Mousavi SA,et al.Role of urinary levels of endothelin-1,monocyte chemotactic peptide-1,and N-acetyl glucosaminidase in predicting the severity of obstruction in hydronephrotic neonates[J].Korean J Urol,2014,55(10):670-676.DOI:10.4111/kju.2014.55.10.670.
[58] Skalova S,Rejtar P,Kutilek S.Increased urinary N-acetyl-beta-D-glucosaminidase activity in children with hydronephrosis[J].Int Braz J Urol,2007,33(1):80-86.DOI:10.1590/s1677-55382007000100014.
[59] Taha MA,Shokeir AA,Osman HG,et al.Diagnosis of ureteropelvic junction obstruction in children:role of endothelin-1 in voided urine[J].Urology,2007,69(3):560-564.DOI:10.1016/j.urology.2006.09.070.